Microvast (NASDAQ:MVST - Get Free Report) posted its quarterly earnings data on Monday. The company reported ($0.20) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.02 by ($0.22), FiscalAI reports. Microvast had a net margin of 13.95% and a negative return on equity of 10.34%. The company had revenue of $45.81 million during the quarter, compared to the consensus estimate of $80.25 million.
Here are the key takeaways from Microvast's conference call:
- Q3 revenue fell 62.8% year over year as sales volume dropped amid weaker demand in Europe and APAC and lower U.S. sales. Gross margin declined to 5.2% from 37.6%, reflecting inventory write-downs, lower volume, and continued pricing pressure.
- Microvast reported a $76.8 million GAAP net loss and negative $60.8 million adjusted EBITDA for the quarter; it also recorded $35.7 million in non-cash asset impairments. Cash and restricted cash ended the quarter at $124.4 million after falling $44.8 million over nine months.
- Management said substantial doubt about the company’s ability to continue as a going concern remains, with significant near-term debt maturities and lender negotiations underway. The company is pursuing cost cuts, reduced capital spending, and potential asset sales, but said there is no assurance these efforts or debt negotiations will succeed.
- Microvast completed installation and commissioning of its Huzhou Phase 3.2 production equipment, but ramp-up depends on demand, qualification, yields, efficiency, and working capital; the line may operate below capacity without a significant volume increase. Solid-state and silicon-sulfur prototypes showed preliminary lab progress, but remain early-stage and require further validation and scale-up.
Microvast Price Performance
Shares of MVST traded down $0.01 during mid-day trading on Monday, hitting $0.62. The company's stock had a trading volume of 5,617,323 shares, compared to its average volume of 4,766,146. The company has a debt-to-equity ratio of 0.03, a current ratio of 1.09 and a quick ratio of 0.82. The firm has a 50-day moving average price of $0.61 and a 200 day moving average price of $1.34. Microvast has a fifty-two week low of $0.47 and a fifty-two week high of $5.30. The stock has a market capitalization of $238.31 million, a price-to-earnings ratio of -30.88 and a beta of 3.72.
Wall Street Analysts Forecast Growth
Several equities research analysts recently commented on MVST shares. HC Wainwright dropped their target price on Microvast to $4.00 and set a "buy" rating on the stock in a report on Thursday, August 13th. Weiss Ratings raised Microvast from a "sell (d-)" rating to a "sell (d+)" rating in a research note on Tuesday, August 11th. Finally, Zacks Research upgraded Microvast from a "strong sell" rating to a "hold" rating in a research report on Monday, July 13th. One analyst has rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company's stock. According to data from MarketBeat.com, Microvast presently has an average rating of "Hold" and an average target price of $4.00.
Check Out Our Latest Analysis on MVST
About Microvast
(
Get Free Report)
Microvast Holdings, Inc develops and manufactures lithium-ion battery technologies and energy storage solutions. The company offers battery cells, modules and packs, along with related battery components and systems designed for commercial vehicles, specialty vehicles, passenger vehicles and stationary energy storage applications.
Microvast emphasizes a vertically integrated approach that spans battery materials, cell development, manufacturing and system integration. Its product portfolio includes battery technologies based on different chemistries and form factors, allowing it to serve applications with varying requirements for energy density, power, safety, charging performance and operating life.
Founded in 2006 and headquartered in Stafford, Texas, Microvast serves customers in the United States, Europe and Asia.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Microvast, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Microvast wasn't on the list.
While Microvast currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.